Literature DB >> 15769794

Measurement of interstitial insulin in human adipose and muscle tissue under moderate hyperinsulinemia by means of direct interstitial access.

Manfred Bodenlenz1, Lukas A Schaupp, Tatjana Druml, Romana Sommer, Andrea Wutte, Helga C Schaller, Frank Sinner, Paul Wach, Thomas R Pieber.   

Abstract

Insulin's action to stimulate glucose utilization is determined by the insulin concentration in interstitial fluid (ISF) of insulin-sensitive tissues. The concentration of interstitial insulin has been measured in human subcutaneous adipose tissue and skeletal muscle, however, never in parallel. The aim of this study was to compare interstitial insulin levels between both tissue beds by simultaneous measurements and to verify and quantify low peripheral ISF insulin fractions as found during moderate hyperinsulinemia. Nine healthy subjects (27.2 +/- 0.8 yr) were investigated. A euglycemic-hyperinsulinemic clamp was started with a primed-constant intravenous insulin infusion of 1 mU x kg(-1) x min(-1). For direct access to ISF, macroscopically perforated open-flow microperfusion catheters were inserted in both tissues. During steady-state conditions (9.5 h), interstitial effluents were collected in 30-min fractions using five different insulin concentrations in the inflowing perfusates ("no net flux" protocol). Regression analysis of insulin concentrations in perfusates and effluents yielded the relative recovery and the perfusate insulin concentration, which was in equilibrium with the surrounding tissue. Thus, in subcutaneous adipose tissue and skeletal muscle, the mean ISF-to-serum insulin level was calculated as 21.0% [95% confidence interval (CI) 17.5-24.5] and 26.0% (95% CI 19.1-32.8; P = 0.14), respectively. Recoveries for insulin averaged 51 and 64%, respectively. The data suggest that the concentrations of insulin arising in healthy subjects at the level of ISF per se are comparable between subcutaneous adipose and skeletal muscle tissue. The low interstitial insulin fractions seem to confirm reports of low peripheral insulin levels during moderate insulin clamps.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769794     DOI: 10.1152/ajpendo.00431.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  10 in total

1.  Transendothelial movement of adiponectin is restricted by glucocorticoids.

Authors:  Thanh Q Dang; Nanyoung Yoon; Helen Chasiotis; Emily C Dunford; Qilong Feng; Pingnian He; Michael C Riddell; Scott P Kelly; Gary Sweeney
Journal:  J Endocrinol       Date:  2017-08       Impact factor: 4.286

Review 2.  The barrier within: endothelial transport of hormones.

Authors:  Cathryn M Kolka; Richard N Bergman
Journal:  Physiology (Bethesda)       Date:  2012-08

3.  Comparison of open-flow microperfusion and microdialysis methodologies when sampling topically applied fentanyl and benzoic acid in human dermis ex vivo.

Authors:  R Holmgaard; E Benfeldt; J B Nielsen; C Gatschelhofer; J A Sorensen; C Höfferer; M Bodenlenz; T R Pieber; F Sinner
Journal:  Pharm Res       Date:  2012-03-15       Impact factor: 4.200

4.  Microneedle-based automated therapy for diabetes mellitus.

Authors:  Puneet Khanna; Joel A Strom; John I Malone; Shekhar Bhansali
Journal:  J Diabetes Sci Technol       Date:  2008-11

5.  Regulation of Adipose Tissue Metabolism in Humans: Analysis of Responses to the Hyperinsulinemic-Euglycemic Clamp Experiment.

Authors:  Jaeyeon Kim; Gerald M Saidel; Satish C Kalhan
Journal:  Cell Mol Bioeng       Date:  2011-06-01       Impact factor: 2.321

Review 6.  Altered transendothelial transport of hormones as a contributor to diabetes.

Authors:  Nanyoung Yoon; Thanh Q Dang; Helen Chasiotis; Scott P Kelly; Gary Sweeney
Journal:  Diabetes Metab J       Date:  2014-04       Impact factor: 5.376

7.  A mathematical model of brain glucose homeostasis.

Authors:  Lu Gaohua; Hidenori Kimura
Journal:  Theor Biol Med Model       Date:  2009-11-27       Impact factor: 2.432

8.  A Generic Integrated Physiologically based Whole-body Model of the Glucose-Insulin-Glucagon Regulatory System.

Authors:  S Schaller; S Willmann; J Lippert; L Schaupp; T R Pieber; A Schuppert; T Eissing
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-08-14

9.  Long-term implanted cOFM probe causes minimal tissue reaction in the brain.

Authors:  Thomas Birngruber; Arijit Ghosh; Sonja Hochmeister; Martin Asslaber; Thomas Kroath; Thomas R Pieber; Frank Sinner
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

10.  Insulin Enhances the In Vitro Osteogenic Capacity of Flexor Tendon-Derived Progenitor Cells.

Authors:  Sushmitha S Durgam; Nadine N Altmann; Haley E Coughlin; Audrey Rollins; Laura D Hostnik
Journal:  Stem Cells Int       Date:  2019-12-27       Impact factor: 5.443

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.